Washington Trust’s CorMedix CRMD Stock Holding History

Washington Trust’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,950	Closed	-$32K	–	222
2018 Q4	$32K	Hold	4,950	–	–	﹤0.01%	216
2018 Q3	$24K	Hold	4,950	–	–	﹤0.01%	228
2018 Q2	$6K	Hold	4,950	–	–	﹤0.01%	731
2018 Q1	$4K	Hold	4,950	–	–	﹤0.01%	225
2017 Q4	$12K	Hold	4,950	–	–	﹤0.01%	226
2017 Q3	$13K	Hold	4,950	–	–	﹤0.01%	219
2017 Q2	$11K	Hold	4,950	–	–	﹤0.01%	211
2017 Q1	$40K	Hold	4,950	–	–	﹤0.01%	201
2016 Q4	$38K	Hold	4,950	–	–	﹤0.01%	209
2016 Q3	$62K	Hold	4,950	–	–	﹤0.01%	204
2016 Q2	$49K	Hold	4,950	–	–	﹤0.01%	204
2016 Q1	$66K	Hold	4,950	–	–	﹤0.01%	200
2015 Q4	$50K	Hold	4,950	–	–	﹤0.01%	203
2015 Q3	$49K	Hold	4,950	–	–	﹤0.01%	202
2015 Q2	$96K	Hold	4,950	–	–	0.01%	210
2015 Q1	$244K	Hold	4,950	–	–	0.02%	193
2014 Q4	$47K	Buy	+4,950	New	+$39.4K	﹤0.01%	209

Other funds holding CRMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $34.8M AUM 275.91% 1-Year Est. Return

Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Washington Trust's CRMD Position: Q1 2019 in Review

Washington Trust sold out of CorMedix (CRMD) in Q1 2019, closing a stake of 4,950 shares — an estimated $32K sold.

Washington Trust first reported a position in CRMD in Q4 2014 and held it in 17 quarters. The position peaked at $244K in Q1 2015. 40 funds tracked by Wall St. Rank hold CRMD as of Q1 2019.

Washington Trust reported no remaining CorMedix position as of Q1 2019 after selling out during the quarter.
Washington Trust sold 4,950 CorMedix shares in Q1 2019, an estimated $32K.
Washington Trust first reported a position in CorMedix in Q4 2014 and held it in 17 quarters.
Washington Trust's CorMedix position peaked at $244K in Q1 2015.
40 funds tracked by Wall St. Rank held CorMedix as of Q1 2019.

Based on Washington Trust's 13F filing for Q1 2019, filed 13 May 2019.